RUSSELL TANNER: Open Payments
NPI 1871544486 · BRIDGEPORT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 9 companies in 2025. Trend: 2023 $212 · 2024 $171 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Echosens North America, Inc. | 3 | $87 |
| Antares Pharma, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Fibroscan, XYOSTED, MOUNJARO, AIRSUPRA, Symbravo, OTEZLA, Ozempic, INSPIRE.
Industry payments across TX — which companies pay providers there.
